| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $72.8M | +91.9% |
| SG&A Expense | $32.9M | +45.9% |
| Operating Income | -$105.6M | -74.8% |
| Income Tax | $0 | — |
| Net Income | -$101.1M | -42.8% |
| EPS (Basic) | -$1.84 | +24.9% |
| EPS (Diluted) | -$1.84 | +24.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.7M | -87.3% |
| Current Assets | $275.4M | -27.9% |
| Total Assets | $321.9M | -19.9% |
| Current Liabilities | $13.0M | +7.4% |
| Total Liabilities | $25.6M | +42.8% |
| Stockholders' Equity | $296.3M | -22.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.0M | -66.5% |
| Capital Expenditures | $6.6M | +14.9% |
| Investing Cash Flow | -$241.9M | -4113.6% |
| Financing Cash Flow | $597K | -99.9% |
| Free Cash Flow | -$94.6M | -61.4% |